BERG, the clinical stage biotech that employs patient biology and artificial intelligence (AI) to research diseases…
Author: admin
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Hoth Therapeutics, Inc., (NASDAQ: HOTH) a patient focused biopharmaceutical company, announced today that it has entered into two…
Diamond Therapeutics Announces First Patient Dosed in Clinical Trial Evaluating Low-Dose Psilocybin
Diamond Therapeutics Inc. (“Diamond”), a drug development company focused on non-hallucinogenic, psychedelic-based therapies for use in…
Medical Cannabis Market to Reach $53.88 Bn, Globally, by 2030 at 23.6% CAGR: Allied Market Research
Allied Market Research published a report, titled, “Medical Cannabis Market by Product Type (Buds/Marijuana Flower and Cannabis Extracts),…
AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman…
Cryoport, Inc. Prices Upsized $350.0 Million Convertible Senior Notes Offering
Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry,…
Smith+Nephew establishes its first Medical Education Centre for the Asia Pacific region in Singapore
Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces its first dedicated Medical Education Centre to…
Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market
Creative Medical Technology Holdings, Inc. (the “Company”), a commercial stage biotechnology company focused on immunology, urology,…
Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards
Johnson & Johnson (NYSE: JNJ) today announced that it has provided a $5MM endowment to Research!America to…
Kodiak Sciences Announces Third Quarter 2021 Financial Results and Recent Business Highlights
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to…